Red Light Holland Highlights Publication of Randomized Clinical Trial Showing a Single Dose of Psilocybin Reduced Cocaine Use, with Filament Health Holding the Exclusive License to the Data and Intellectual Property
· red light holland corp
AI Briefing
- A single dose of psilocybin reduced cocaine use in adults with cocaine use disorder.
- The trial's findings were published in JAMA Network Open on May 7, 2026.
- Filament Health holds the exclusive worldwide license to the trial data and intellectual property.
Advertisement